iPACES v4 for Parkinson's Disease and Mild Cognitive Impairment
This study is looking at how a special type of exercise, called neuro-exergaming, might help people with Parkinson's Disease (PD) and Mild Cognitive Impairment (MCI). You would use a device called iPACES or PACE, which combines physical activity (pedaling) with mental challenges from a tablet game. Researchers want to see if iPACES, where pedaling directly controls the game, is more helpful than PACE, where you pedal and play the game separately. The main goal is to see if these exercises improve your executive function (like planning and problem-solving) and everyday function after 3 months. The study plans to enroll 120 participants aged 50 or older who have MCI.
- Study design
- This interventional study plans to enroll 120 participants. It compares two different ways of combining physical and cognitive exercise.
- What's involved
- You would exercise at home 3-5 times per week for at least 6 months, with follow-up one month after the main intervention. This includes tablet surveys and videoconference evaluations for one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will have a follow-up one month after the main intervention, and evaluations will continue for one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS
At a glance
Conditions
NCT05810454
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
remote trial conducted in-home or nearby, across the USA; via iPACES app/video-conference/mail
Clifton Park, New Yorkstudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Bob Gillen, PhD · PRINCIPAL_INVESTIGATOR · iPACES LLC
- Cay Anderson-Hanley, PhD · PRINCIPAL_INVESTIGATOR · iPACES LLC
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- executive functionchange from baseline to 3 months
cognitive function composite score from neuropsychological tests (e.g., Stroop); higher scores on the standardized composite would be centered around zero, and higher scores would indicate better performance
- everyday functionchange from baseline to 3 months
subjective cognitive function in everyday living (e.g., Ecological Validity Scale); higher scores would indicate better outcomes